DBT Skills Expanded With Contextual Intervention for Long Lasting Symptoms in Borderline Personality Disorder (DBT+Context)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05972096 |
Recruitment Status :
Recruiting
First Posted : August 2, 2023
Last Update Posted : August 2, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Borderline Personality Disorders BPD | Behavioral: Combination DBT, self-compassion and contextual-based skills | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Randomized clinical trial aims to test the efficacy of this expanded skills DBT-based intervention with self-compassion and contextual-based skills targeting long-lasting BPD compared with treatment as usual. |
Masking: | Single (Investigator) |
Primary Purpose: | Treatment |
Official Title: | Clinical Trial of Skills Training for Long Lasting Symptoms in Borderline Personality Disorder |
Actual Study Start Date : | March 1, 2022 |
Estimated Primary Completion Date : | October 1, 2023 |
Estimated Study Completion Date : | October 1, 2023 |
Arm | Intervention/treatment |
---|---|
Experimental: Combination of DBT-ST, self-compassion, and contextual-based skills.
Combination of DBT-ST, self-compassion, and contextual-based skills.
|
Behavioral: Combination DBT, self-compassion and contextual-based skills
Psychotherapy combination. Skills of DBT plus self-compassion and contextual skills |
Placebo Comparator: Control Group
Treatment as usual. Although these individuals did not receive any new specific psychotherapeutic intervention for BPD, they valued the higher frequency of psychiatric visits, attention in crisis, family care, and greater experience and sensitivity in the management of BPD.
|
Behavioral: Combination DBT, self-compassion and contextual-based skills
Psychotherapy combination. Skills of DBT plus self-compassion and contextual skills |
- Pemberton Happiness Index (PHI) [ Time Frame: 1 month ]Happiness index (minimum 0- maximum 110) Higher scores better
- Borderline Symptoms List-23 (BSL-23) [ Time Frame: 1 week ]Symptoms of Borderline (minimum 0- maximum 92). Higher scores worse
- Remission from Depression Questionnaire (RDQ) [ Time Frame: 1 week ]Depression (minimum 0- maximum 84). Higher scores worse
- Self Compassion Scale Short Form (SCS-SF) [ Time Frame: 1 month ]Compassion scale (12 items, minimum 12- maximum 60). Higher scores worse
- Forms of Self-Criticism/Self-Attacking and Self-Reassuring Scale (FSCRS) [ Time Frame: 1 month ]Self-criticism forms (14 items, minimum 0- maximum 56). Higher scores worse
- Satisfaction with life scale (SWLS) [ Time Frame: 1 month ]Well being (5 items, minimum 5 - maximum 25). Higher scores better
- Quality of life scale (WHO-QOL_BREF) [ Time Frame: 2 weeks ]Quality of life OMS (26 items, minimum 26- maximum 130). Higher scores better
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adults between 18 and 65 years of age
- Primary diagnosis of BPD according to Diagnostic Statistical Manual IV criteria and by the structured interviews: Diagnosis Structured clinical interview for axis II personality disorders (SCID II; First et al. 1997) and Diagnostic Interview for Borderlines Revised (DIB-R)
- Previous participation in DBT-ST intervention
- Signed informed consent.
Exclusion Criteria:
- Presence of life-threatening behaviors in the last 12 months
- PTSD or related symptoms
- Diagnosis of drug-induced psychosis, organic brain syndrome, bipolar or psychotic disorder
- Intellectual disability
- Participation in any other psychotherapy treatment during the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05972096
Contact: Juan Carlos Pascual, PhD | 34935537840 | jpascual@santpau.cat |
Spain | |
Juan Carlos Pascual Mateos | Recruiting |
Barcelona, Spain, 08041 | |
Contact: Juan Carlos Pascual, PhD +34935537840 jpascual@santpau.cat |
Principal Investigator: | Joaquim Soler, PhD | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
Responsible Party: | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
ClinicalTrials.gov Identifier: | NCT05972096 |
Other Study ID Numbers: |
IIBSP-TLP-2020-104 |
First Posted: | August 2, 2023 Key Record Dates |
Last Update Posted: | August 2, 2023 |
Last Verified: | July 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
borderline personality disorder long-lasting symptoms dialectical behavior therapy skills contextual approach. |
Personality Disorders Borderline Personality Disorder Mental Disorders |